Micronoma Announcements
Micronoma, University of New South Wales Tackle Liver Cancer with $4 Million Grant
Research uses circulating microbiome biomarkers, machine learning for early detection July 20, 2021 – San Diego, Calif. Micronoma, the first cancer detection company to harness tumor-associated circulating microbial biomarkers to diagnose cancer at an early stage...
Micronoma Welcomes Esteemed Clinical Oncologist to Scientific Advisory Board
Jennifer Wargo, M.D., leads research on link between microbiome and cancer treatment and recently co-authored Science review with Micronoma founders San Diego, Calif. (April 6, 2021) - San Diego, Calif. Micronoma, the first cancer detection biotech company that...
Micronoma Raises $3.5 Million in Convertible Note Financing
Investors more than double funding base for cancer microbiome diagnostic company to accelerate go-to-market timeline six months after seed February 17, 2021 -- San Diego, Calif. Micronoma, the first cancer detection biotech company that utilizes signals from the...
Micronoma Establishes Scientific Advisory Board
International oncology, microbiome and drug discovery expertise synergize to guide unique early cancer detection startup SAN DIEGO, Dec. 9, 2020 /PRNewswire/ -- Micronoma, the first cancer detection biotech company that uses signals from the tumor-related microbiome...
Micronoma Expands Executive Team and Operations
Innovative early cancer detection company establishes headquarters and adds three key executive positions San Diego, Calif. (November 5, 2020). Micronoma, an early-stage cancer detection biotech company seeking to develop and commercialize a minimally-invasive, unique...
Micronoma Appoints Magda Marquet Chairman of the Board
Biotech maven joins early-stage cancer detection company utilizing innovative microbiome analysis SAN DIEGO, Sept. 30, 2020 /PRNewswire/ -- Micronoma, an early stage cancer-detection start-up seeking to develop and commercialize a minimally-invasive, unique...
Micronoma Launches with $3 Million Seed Funding
For Immediate Release Media Contact: Celia Sepulveda, Celia.Sepulveda@Micronoma.com, 858.337.1326 Micronoma Launches with $3 Million Seed Funding First early cancer-detection company to use microbial biomarkers in diagnostics San Diego, Calif....
UCSD team, and Micronoma founders, publish Nature paper identifying nucleic acid-based, tumor-specific microbial signatures in the blood, suggesting a new diagnostic approach.
Microbiome analyses of blood and tissues suggest cancer diagnostic approach.
Systematic characterization of the cancer microbiome provides the opportunity to develop techniques that exploit non-human, microorganism-derived molecules in the diagnosis of a major human disease.
Micronoma to Present at Biocom’s 10th Annual Global Life Science Partnering Conference
Micronoma will be presenting at Biocom this year. Go to Biocom Micronoma San Diego, CA, USA info@micronoma.comlinkedin
Contact Us
If you have questions or would like to learn more, please email us at info@micronoma.com or contact us.
Micronoma
6342 Ferris Square
San Diego, CA 92121